Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503643 · ClinicalTrials.gov registry record
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 354
- Enrollment target
NCT03503643: Completed study, sponsored by Jonsson Comprehensive Cancer Center.
NCT03503643 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 354 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503643 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
Study Summary
This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.
Primary Outcome
Our primary endpoint will be a patient's clinical response to cancer treatment, specifically, the degree of prostate cancer on a post-treatment fusion biopsy compared to pre-treatment.
Interventions
- DEVICE Hemigland Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2025-08-30 |
What the finished NCT03503643 record still lists
NCT03503643 is an observational study that tracks outcomes without assigning an intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Hemigland Cryoablation is the first listed.
NCT03503643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03503643 about?
NCT03503643 is a clinical study titled "Hemi-Gland Cryoablation for Prostate Cancer at UCLA". This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation a...
What is the current status of trial NCT03503643?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2017-09-14. Estimated completion is 2025-08-30.
What interventions are being tested in trial NCT03503643?
The interventions under investigation include: Hemigland Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT03503643?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI